how is oral anticoagulant-associated intracerebral hemorrhage currently managed?
Published 1 year ago • 279 plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
3:40
reversal agents for the management of oral anticoagulant-associated ich
-
3:22
risk factors for oral anticoagulant-associated ich
-
4:46
anti-fxa anticoagulation reversal strategies: current evidence
-
9:12
tich-noac: tranexamic acid for the treatment of novel oral anticoagulant-associated ich
-
2:35
restarting anticoagulation after hemorrhagic stroke
-
3:06
trials assessing anticoagulation after ich in patients with atrial fibrillation
-
34:25
reversal agents for direct oral anticoagulants for patients experiencing intracerebral haemorrhage
-
3:35
restarting anticoagulation after ich in patients with atrial fibrillation
-
35:27
intracranial haemorrhage related to direct oral anticoagulant medications
-
56:53
anticoagulation and intracranial hemorrhage
-
30:45
overview of intracerebral hemorrhage (ich) — causes, bp management, anticoagulation reversal
-
22:25
acute gi bleeding, oral anticoagulant therapy, and reversal strategies
-
20:59
the blessing and curse of direct oral anticoagulants in the bleeding patient
-
7:58
should anticoagulation be restarted after ich for stroke prevention in atrial fibrillation?
-
5:30
pharmacology: anticoagulants, animation
-
28:27
managing bleeding events in patients receiving direct oral anticoagulants
-
7:20
case 3: anticoagulant-related bleeding
-
38:00
reversing doacs: providing answers on why, when, and how
-
8:00
unresolved questions on post-stroke anticoagulation in atrial fibrillation